MOGN Insider Trading Activity and SEC Form 4 Filings
MOGN insider trading summary
No open-market insider purchases or sales of Mgi Pharma Inc (MOGN) have been reported on SEC Form 4 in the past 12 months.
Latest MOGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 15, 2006 | Andrew J Ferrara | Director | Buy | $28K (2,000 @ $14.02) |
| Aug 9, 2006 | Hugh E Miller | Director | Buy | $55K (4,000 @ $13.69) |
| Aug 8, 2006 | Waneta C Tuttle | Director | Buy | $20K (1,500 @ $13.64) |
| Aug 8, 2006 | Waneta C Tuttle | Director | Buy | $7K (500 @ $13.63) |
| Aug 8, 2006 | David B Sharrock | Director | Buy | $28K (2,000 @ $14.00) |
| Aug 8, 2006 | David B Sharrock | Director | Buy | $27K (2,000 @ $13.61) |
| Aug 7, 2006 | William Spengler | Executive VP, CFO | Buy | $14K (1,000 @ $13.85) |
| Aug 7, 2006 | Arthur L Weaver | Director | Buy | $28K (2,000 @ $13.94) |
| Aug 4, 2006 | Leon O Moulder Jr | President & CEO | Buy | $10K (700 @ $14.15) |
| Aug 4, 2006 | Leon O Moulder Jr | President & CEO | Buy | $18K (1,300 @ $14.16) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.